In pancreatic cancer, active CDK5 phosphorylates enhancer of zeste homolog 2 (EZH2), which triggers its degradation via FBW7, a component of ubiquitin ligase (Table 2). The gene discussed is EZH2; the disease is familial pancreatic carcinoma.